- Home
- CERT
CERT
Certara Inc.
as 05-09-2024 4:00pm EST
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 2.6B | IPO Year: | 2020 |
| Target Price: | $46.81 | AVG Volume (30 days): | 542.3K |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.81 - $22.65 | Next Earning Date: | 05-07-2024 |
| Revenue: | $360,690,000 | Revenue Growth: | 4.73% |
| Revenue Growth (this year): | 11.81% | Revenue Growth (next year): | 10.65% |
Share on Social Networks:
Stock Insider Trading Activity of Certara Inc. (CERT)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $16.76 | 5,264 | $88,224.64 | 59,254 | SEC Form 4 |
| SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $17.72 | 649 | $11,500.28 | 58,605 | SEC Form 4 |
| SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $16.75 | 3,024 | $50,652.00 | 55,581 | SEC Form 4 |
| SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $17.67 | 328 | $5,795.76 | 55,253 | SEC Form 4 |
| SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $16.77 | 4,740 | $79,489.80 | 50,513 | SEC Form 4 |
| SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Apr 2 '24 | Sell | $17.77 | 422 | $7,498.94 | 50,091 | SEC Form 4 |
| Traynor Richard M. | CERT | SVP AND GENERAL COUNSEL | Mar 4 '24 | Sell | $18.28 | 3,000 | $54,840.00 | 162,368 | SEC Form 4 |
| SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Feb 20 '24 | Sell | $18.00 | 5,000 | $90,000.00 | 54,975 | SEC Form 4 |
| Traynor Richard M. | CERT | SVP AND GENERAL COUNSEL | Feb 12 '24 | Sell | $18.00 | 6,000 | $108,000.00 | 165,368 | SEC Form 4 |
Latest Certara Inc. News
CERT Breaking Stock News: Dive into CERT Ticker-Specific Updates for Smart Investing
Insider Monkey
8 hours ago
Certara, Inc. (NASDAQ:CERT) Q1 2024 Earnings Call Transcript
Simply Wall St.
15 hours ago
Certara First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Thomson Reuters StreetEvents
a day ago
Q1 2024 Certara Inc Earnings Call
MT Newswires
2 days ago
Certara Q1 Adjusted Earnings Down, Revenue Increases
GuruFocus.com
2 days ago
Certara Inc (CERT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
Zacks
2 days ago
Certara, Inc. (CERT) Q1 Earnings Meet Estimates
GuruFocus.com
2 days ago
Certara Inc (CERT) Q1 2024 Earnings: Mixed Results Amidst Revenue Growth and Net Loss
GlobeNewswire
2 days ago